Understanding Osteoporosis through Body Chemistry
Comprehensive Metabolomics Study of Osteoporosis
This project aims to find new ways to predict, diagnose, and treat osteoporosis by looking closely at the chemical makeup of our bodies, especially in older adults and different ethnic groups.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11118855 on NIH RePORTER |
What this research studies
Osteoporosis is a common bone disease that makes bones weak and prone to fractures, and we currently lack good ways to understand and treat it. This project explores the body's chemical profiles, called metabolomics, to uncover new clues about why some people get osteoporosis and others don't. By studying these chemical patterns in diverse groups, including older adults and different ethnicities, we hope to find new markers that can help us better predict who is at risk and develop more effective treatments. We will also work to confirm the identity and role of these chemical markers in bone health.
Who could benefit from this research
Good fit: Patients who are older adults, particularly those with or at risk for osteoporosis, and individuals from diverse ethnic backgrounds, especially African Americans, may be ideal candidates for future related studies.
Not a fit: Patients whose condition is not related to osteoporosis or metabolic bone health may not directly benefit from this specific line of inquiry.
Why it matters
Potential benefit: If successful, this work could lead to earlier detection, more accurate diagnoses, and new treatment options for osteoporosis, potentially reducing the risk of fractures.
How similar studies have performed: While metabolomics has shown promise in other disorders, comprehensive human metabolomics for osteoporosis, particularly addressing sex and ethnic differences, is still a relatively new and understudied area.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Zhao, Qi — Tulane University of Louisiana
- Study coordinator: Zhao, Qi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.